GLP-1 Market
LLY $1240.34 ▼ -1.3% NVO $38.42 ▼ -1.1% PFE $29.44 ▼ -0.5% VKTX $25.05 ▼ -0.5% KLRA $11.43 ▲ +1.6% GPCR $22.01 ▲ +4.4% RHHBY $57.14 • 0.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Topiramate

Company
University of California, Irvine
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
13 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

13 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 20, 2026

Find a Clinical Trial Near Me

See recruiting studies for Topiramate and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03511118

    Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

    Duke University 1600 participants Est. completion 2028-07-31 22 sites
    Other conditions: Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI
    View official trial listing →
  • Recruiting NCT NCT03667846

    Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD

    Not yet reported NYU Langone Health 150 participants Est. completion 2025-08-31 1 site Stand-alone
    Alcohol use disorder Other conditions: Post Traumatic Stress Disorder
    View official trial listing →
  • Recruiting NCT NCT04721873

    Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

    Not yet reported University of California, San Diego 40 participants Est. completion 2024-06-30 1 site Stand-alone
    Other conditions: Colitis, Ulcerative, Obesity
    View official trial listing →
  • Recruiting NCT NCT05263674

    Fast Acute Sedation at Intensive Care vs. High-dose i.v. Anti-seizure Medication for Treatment of Non-convulsive Status Epilepticus (FAST-trial)

    Not yet reported University of Southern Denmark 140 participants Est. completion 2028-12-31 5 sites
    Other conditions: Non-Convulsive Status Epilepticus
    View official trial listing →
  • Recruiting NCT NCT05582837

    Treatment of Meniere's Disease With Migraine Medications

    Not yet reported University of California, Irvine 40 participants Est. completion 2027-12-30 1 site Stand-alone
    Other conditions: Ménière
    View official trial listing →
  • Recruiting NCT NCT05925959

    Preoperative Weight Loss for Open Abdominal Wall Reconstruction

    Not yet reported Benjamin T. Miller 258 participants Est. completion 2027-06-01 2 sites
    Other conditions: Abdominal Wall Hernia
    View official trial listing →
  • Recruiting NCT NCT05975580

    Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery

    Not yet reported University of California, Irvine 120 participants Est. completion 2028-01-31 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT06303778

    Combining a Smartphone App With Medications to Manage Heavy Drinking

    Not yet reported VA Office of Research and Development 330 participants Est. completion 2028-11-01 15 sites
    Alcohol use disorder
    View official trial listing →
  • Recruiting NCT NCT06322407

    Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult

    Not yet reported Beijing Tiantan Hospital 206 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Chronic Migraine
    View official trial listing →
  • Recruiting NCT NCT06972056

    Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    Not yet reported Mayo Clinic 1335 participants Est. completion 2029-12-01 37 sites
    Other conditions: Migraine
    View official trial listing →
  • Recruiting NCT NCT07058155

    Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

    Not yet reported The Cleveland Clinic 70 participants Est. completion 2034-02-01 1 site
    Other conditions: Liver Cirrhoses, Portal Hypertension Related to Cirrhosis, Severe Obesity, TIPS
    View official trial listing →
  • Recruiting NCT NCT07213466

    Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

    Not yet reported Mayo Clinic 100 participants Est. completion 2029-02-01 1 site Stand-alone
    Other conditions: Bipolar I Disorder, Bipolar II Disorder, Schizo Affective Disorder, Obesity, Weight Loss, GLP - 1
    View official trial listing →
  • Recruiting NCT NCT07413731

    Neurophysiological Effects of Medication Tapering During Treatment With Spinal Cord Stimulation

    Brai²n 50 participants Est. completion 2027-04-03 1 site
    Other conditions: Persistent Spinal Pain Syndrome Type 2 (PSPS-T2), Lower Spine, Spinal Cord Sensitivity to Neurostimulation, Neurophysiological Sensitivity to Spinal Cord Stimulation
    View official trial listing →
  • Completed NCT NCT00001725

    Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain

    Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 100 participants Est. completion 2002-01 1 site
    Other conditions: Facial Neuralgia, Pain, Trigeminal Neuralgia
    View official trial listing →
  • Completed NCT NCT00004776

    Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome

    Not yet reported National Center for Research Resources (NCRR) 10 participants
    Other conditions: Lennox-Gastaut Syndrome
    View official trial listing →
  • Completed NCT NCT00004807

    Study of the Pathogenesis of Rett Syndrome

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 120 participants
    Other conditions: Rett Syndrome
    View official trial listing →
  • Status unknown NCT NCT00006205

    Alcohol Dependency Study: Combining Medication Treatment for Alcoholism

    Not yet reported Bankole Johnson 320 participants Est. completion 2013-12 2 sites Stand-alone
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT00011804

    Topiramate in the Treatment of Sciatica

    Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 65 participants Est. completion 2005-02 1 site
    Other conditions: Sciatica
    View official trial listing →
  • Completed NCT NCT00035230

    A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 338 participants Est. completion 2002-11
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00035802

    A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 13 participants Est. completion 2002-04 Stand-alone
    Other conditions: Bipolar Disorder, Affective Disorders, Psychotic, Mood Disorders, Mental Disorders
    View official trial listing →
  • Completed NCT NCT00037674

    A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 434 participants Est. completion 2003-05
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00065923

    Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 10 participants 1 site
    Other conditions: Prader-Willi Syndrome, Self-Injurious Behavior
    View official trial listing →
  • Terminated NCT NCT00068770

    Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35 participants Est. completion 2006-05 7 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00113815

    Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 118 participants Est. completion 2007-11 94 sites Stand-alone
    Other conditions: Partial Seizure Disorder, Epilepsy, Seizures
    View official trial listing →
  • Completed NCT NCT00131443

    Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine

    Not yet reported, Not yet reported Monarch Medical Research 40 participants Est. completion 2006-08 1 site
    Other conditions: Basilar Migraine
    View official trial listing →
  • Status unknown NCT NCT00153699

    Relationship Between Topiramate Use and Ocular Angle Status

    Not yet reported Chinese University of Hong Kong 15 participants Est. completion 2007-07 2 sites
    Other conditions: Glaucoma, Angle-Closure
    View official trial listing →
  • Completed NCT NCT00154076

    A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

    Not yet reported Eisai Korea Inc. 140 participants Est. completion 2008-12 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT00158002

    A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine

    Not yet reported Monarch Medical Research 40 participants Est. completion 2006-08 1 site
    Other conditions: Basilar Migraine
    View official trial listing →
  • Completed NCT NCT00167245

    Topiramate for Alcohol and Cocaine Dependence

    Not yet reported Kyle Kampman 170 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Alcoholism, Cocaine Dependence
    View official trial listing →
  • Terminated NCT NCT00182455

    Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP)

    Not yet reported McMaster University 12 participants Est. completion 2018-12-01 1 site Stand-alone
    Other conditions: Social Phobia
    View official trial listing →
  • Completed NCT NCT00182520

    Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)

    Not yet reported McMaster University 23 participants Est. completion 2019-01 1 site Stand-alone
    Other conditions: Obsessive Compulsive Disorder
    View official trial listing →
  • Completed NCT NCT00187928

    Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder

    Not yet reported University of Florida 96 participants Est. completion 2006-03 1 site
    Other conditions: Obsessive-Compulsive Disorder
    View official trial listing →
  • Completed NCT NCT00200941

    Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome

    Not yet reported Neurocare 44 participants Est. completion 2005-04 1 site
    Other conditions: Restless Legs Syndrome
    View official trial listing →
  • Terminated NCT NCT00203190

    A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache

    Not yet reported Thomas Jefferson University 60 participants Est. completion 2006-06 1 site
    Other conditions: Cluster Headache
    View official trial listing →
  • Completed NCT NCT00203463

    Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)

    Not yet reported Tuscaloosa Research & Education Advancement Corporation 40 participants Est. completion 2004-09 1 site
    Other conditions: PTSD
    View official trial listing →
  • Completed NCT NCT00204386

    Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder

    Not yet reported, Not yet reported University of Oklahoma 50 participants Est. completion 2007-05 1 site
    Other conditions: Posttraumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT00206323

    A Randomized, Placebo-controlled, Tourette Syndrome Study.

    Not yet reported Baylor College of Medicine 29 participants Est. completion 2008-12
    Other conditions: Tourette Syndrome
    View official trial listing →
  • Completed NCT NCT00206336

    An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.

    Not yet reported Baylor College of Medicine 20 participants Est. completion 2008-12 Stand-alone
    Other conditions: Tourette Syndrome
    View official trial listing →
  • Completed NCT NCT00208130

    Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians

    Not yet reported Creighton University 60 participants Est. completion 2004-03 1 site
    Other conditions: Post-Traumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT00208858

    A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving

    Not yet reported Emory University Est. completion 2006-12 1 site
    Other conditions: Tobacco Use Disorder
    View official trial listing →
  • Completed NCT NCT00210496

    Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine

    Not yet reported Janssen-Ortho LLC 406 participants Est. completion 2007-06
    Other conditions: Migraine, Classic Migraine, Common Migraine
    View official trial listing →
  • Completed NCT NCT00210535

    A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 110 participants Est. completion 2006-11
    Other conditions: Migraine, Vascular Headaches
    View official trial listing →
  • Completed NCT NCT00210574

    A Pilot Study of Topiramate in Childhood Absence Epilepsy

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 12 participants Est. completion 2006-10
    Other conditions: Epilepsy, Absence
    View official trial listing →
  • Completed NCT NCT00210782

    A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 262 participants Est. completion 2007-08
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT00210808

    A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity

    Not yet reported, Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 407 participants Est. completion 2005-03
    Other conditions: Obesity, Binge-Eating Disorder
    View official trial listing →
  • Completed NCT NCT00210821

    Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine Headaches

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 347 participants Est. completion 2005-11
    Other conditions: Migraine, Headache
    View official trial listing →
  • Completed NCT NCT00210860

    An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 142 participants Est. completion 2006-03
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT00210873

    An Open Label Extension of a Study of Topiramate in Chronic Migraine.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 200 participants Est. completion 2005-08
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT00210912

    A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 328 participants Est. completion 2005-04
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT00210925

    An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol Dependence

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 371 participants Est. completion 2006-08
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT00211744

    Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder

    Not yet reported Montefiore Medical Center 24 participants Est. completion 2006-08 1 site
    Other conditions: Obsessive-compulsive Disorder
    View official trial listing →
  • Completed NCT NCT00212810

    Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.

    Not yet reported Ortho-McNeil Neurologics, Inc. 385 participants Est. completion 2007-08
    Other conditions: Migraine, Headache, Classic Migraine, Common Migraine
    View official trial listing →
  • Completed NCT NCT00216567

    Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy

    Not yet reported Janssen Korea, Ltd., Korea 114 participants Est. completion 2006-02
    Other conditions: Epilepsy, Rolandic
    View official trial listing →
  • Completed NCT NCT00216606

    The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine

    Not yet reported Janssen Pharmaceutica N.V., Belgium 59 participants Est. completion 2005-07
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT00216619

    The Prolonged Use of Topiramate for Preventing Migraine Headaches

    Not yet reported Janssen Pharmaceutica N.V., Belgium 834 participants Est. completion 2006-08 68 sites Stand-alone
    Other conditions: Migraine
    View official trial listing →
  • Status unknown NCT NCT00217295

    A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis

    Not yet reported Multiple Sclerosis Institute 30 participants Est. completion 2007-12 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00223626

    Topiramate to Reduce Cocaine Dependence

    Not yet reported Bankole Johnson 25 participants Est. completion 2010-12 2 sites Stand-alone
    Other conditions: Cocaine-Related Disorders
    View official trial listing →
  • Completed NCT NCT00223639

    New Medications to Treat Alcohol Dependence

    Not yet reported Bankole Johnson 29 participants Est. completion 2008-07 2 sites Stand-alone
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT00230698

    A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 451 participants Est. completion 2002-08
    Other conditions: Epilepsy, Epilepsies, Partial, Seizures
    View official trial listing →
  • Completed NCT NCT00231530

    A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 541 participants Est. completion 2002-05
    Type 2 diabetes Other conditions: Obesity, Diabetes Mellitus, Adult-Onset
    View official trial listing →
  • Completed NCT NCT00231556

    A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 750 participants Est. completion 2003-09
    Other conditions: Epilepsy, Seizures, Epilepsies, Partial, Epilepsy, Generalized, Epilepsy, Tonic-Clonic
    View official trial listing →
  • Completed NCT NCT00231595

    A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 768 participants Est. completion 2002-11
    Other conditions: Migraine, Common Migraine, Classic Migraine, Headache
    View official trial listing →
  • Completed NCT NCT00231608

    A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 68 participants Est. completion 2002-01
    Other conditions: Obesity
    View official trial listing →
  • Terminated NCT NCT00231621

    A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 179 participants Est. completion 2002-06
    Other conditions: Obesity, Hyperlipidemia, Hypertriglyceridemia
    View official trial listing →
  • Terminated NCT NCT00231634

    A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 31 participants Est. completion 2002-11
    Type 2 diabetes Other conditions: Obesity, Diabetes Mellitus, Adult-Onset
    View official trial listing →
  • Completed NCT NCT00231647

    A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 113 participants Est. completion 2004-10
    Type 2 diabetes Other conditions: Obesity, Diabetes Mellitus, Adult-Onset
    View official trial listing →
  • Completed NCT NCT00231660

    A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 211 participants Est. completion 2002-06
    Type 2 diabetes Other conditions: Obesity, Diabetes Mellitus, Adult-Onset
    View official trial listing →
  • Completed NCT NCT00231673

    A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 72 participants Est. completion 2003-01 Stand-alone
    Type 2 diabetes Other conditions: Diabetic Neuropathies, Polyneuropathies
    View official trial listing →
  • Completed NCT NCT00233012

    A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 16 participants Est. completion 2007-10
    Other conditions: Seizures
    View official trial listing →
  • Completed NCT NCT00236418

    A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80 participants Est. completion 1996-12
    Other conditions: Epilepsy, Seizures
    View official trial listing →
  • Completed NCT NCT00236496

    A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating Tremor of Unknown Cause.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 223 participants Est. completion 2004-02
    Other conditions: Essential Tremor
    View official trial listing →
  • Completed NCT NCT00236509

    A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 763 participants Est. completion 2002-09
    Other conditions: Migraine, Common Migraine, Classic Migraine, Headache
    View official trial listing →
  • Completed NCT NCT00236561

    A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 786 participants Est. completion 2002-12
    Other conditions: Migraine, Common Migraine, Classic Migraine, Headache
    View official trial listing →
  • Completed NCT NCT00236600

    A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 561 participants Est. completion 2002-06
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00236613

    A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 385 participants Est. completion 2001-07
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00236626

    A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 38 participants Est. completion 2002-05
    Type 2 diabetes Other conditions: Obesity, Diabetes Mellitus, Adult-Onset
    View official trial listing →
  • Completed NCT NCT00236639

    A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1293 participants Est. completion 2002-06
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00236665

    A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 531 participants Est. completion 2002-06
    Other conditions: Obesity, Hypertension
    View official trial listing →
  • Completed NCT NCT00236691

    A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188 participants Est. completion 1990-12
    Other conditions: Epilepsy, Epilepsies, Partial, Seizures
    View official trial listing →
  • Completed NCT NCT00236704

    A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80 participants Est. completion 1999-12
    Other conditions: Epilepsy, Seizures
    View official trial listing →
  • Completed NCT NCT00236717

    A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 865 participants Est. completion 2000-11
    Other conditions: Epilepsy, Seizures
    View official trial listing →
  • Completed NCT NCT00236730

    A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 178 participants Est. completion 1990-12
    Other conditions: Epilepsy, Epilepsies, Partial, Seizures
    View official trial listing →
  • Completed NCT NCT00236743

    A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 90 participants Est. completion 2000-10
    Other conditions: Epilepsy, Epilepsies, Partial, Seizures
    View official trial listing →
  • Completed NCT NCT00236756

    A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 100 participants Est. completion 2001-02
    Other conditions: Epilepsy, Seizures
    View official trial listing →
  • Completed NCT NCT00236847

    A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60 participants Est. completion 1993-07
    Other conditions: Epilepsy, Epilepsies, Partial, Seizures
    View official trial listing →
  • Completed NCT NCT00236860

    A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 56 participants Est. completion 1992-02
    Other conditions: Epilepsy, Epilepsies, Partial, Seizures
    View official trial listing →
  • Completed NCT NCT00236873

    A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47 participants Est. completion 1993-05
    Other conditions: Epilepsy, Epilepsies, Partial, Seizures
    View official trial listing →
  • Completed NCT NCT00236886

    Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 49 participants Est. completion 2000-06
    Other conditions: Epilepsy, Epilepsies, Partial, Epilepsy, Generalized, Seizures
    View official trial listing →
  • Completed NCT NCT00237289

    Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting

    Not yet reported Ortho-McNeil Neurologics, Inc. 287 participants Est. completion 2003-10
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00237302

    A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children

    Not yet reported Ortho-McNeil Neurologics, Inc. 162 participants Est. completion 2003-09
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT00240721

    A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 363 participants Est. completion 2002-09
    Other conditions: Bipolar Disorders, Mood Disorders, Affective Disorders, Psychotic
    View official trial listing →
  • Suspended NCT NCT00243984

    Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome

    Not yet reported Northeastern Ohio Universities College of Medicine 90 participants Est. completion 2007-11 5 sites
    Metabolic syndromeType 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00245583

    Topiramate in the Treatment of Pathological Gambling

    Not yet reported Icahn School of Medicine at Mount Sinai 42 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Pathological Gambling
    View official trial listing →
  • Status unknown NCT NCT00249691

    Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1

    Not yet reported Bankole Johnson 180 participants Est. completion 2012-10 2 sites Stand-alone
    Other conditions: Cocaine-Related Disorders
    View official trial listing →
  • Completed NCT NCT00253175

    A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 211 participants Est. completion 2001-12
    Other conditions: Vascular Headaches, Migraine
    View official trial listing →
  • Completed NCT NCT00261469

    An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With Triptans

    Not yet reported Janssen-Ortho Inc., Canada 38 participants Est. completion 2004-11
    Other conditions: Headache
    View official trial listing →
  • Completed NCT NCT00266591

    A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 51 participants Est. completion 1997-04
    Other conditions: Epilepsy, Seizures
    View official trial listing →
  • Completed NCT NCT00266604

    A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 409 participants Est. completion 2007-06
    Other conditions: Epilepsy, Seizures, Epilepsies, Partial, Epilepsy, Generalized, Seizures, Tonic-Clonic
    View official trial listing →
  • Completed NCT NCT00280839

    Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation

    Not yet reported Lindner Center of HOPE 87 participants 1 site
    Other conditions: Smoking Cessation
    View official trial listing →
  • Status unknown NCT NCT00286923

    Does Topiramate Adjust the Excitability of the Brain in Migraine Sufferers?

    Emerald City Headache Organization 10 participants Est. completion 2006-08 1 site
    Other conditions: Migraine, Chronic Headache
    View official trial listing →
  • Terminated NCT NCT00286988

    Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in Children

    Not yet reported Monarch Medical Research 12 participants Est. completion 2007-06 1 site
    Other conditions: Vomiting
    View official trial listing →
  • Terminated NCT NCT00296959

    Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease

    Not yet reported University Health Network, Toronto 20 participants Est. completion 2007-03 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00297323

    An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy

    Janssen Cilag Pharmaceutica S.A.C.I., Greece 80 participants Est. completion 2007-02
    Other conditions: Seizures, Epileptic
    View official trial listing →
  • Completed NCT NCT00297336

    An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine

    Janssen Cilag Pharmaceutica S.A.C.I., Greece 80 participants Est. completion 2007-02
    Other conditions: Migraine Disorders
    View official trial listing →
  • Completed NCT NCT00297349

    A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures

    Janssen Cilag Pharmaceutica S.A.C.I., Greece 153 participants Est. completion 2005-06
    Other conditions: Seizures, Epilepsy
    View official trial listing →
  • Completed NCT NCT00300742

    Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals

    Not yet reported University of Virginia 5 participants Est. completion 2008-07 2 sites Stand-alone
    Alcohol use disorder Other conditions: Binge Eating
    View official trial listing →
  • Completed NCT NCT00304603

    Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes Mellitus

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1145 participants Est. completion 2005-04
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00307619

    An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.

    Not yet reported Janssen-Cilag Farmaceutica Ltda. 73 participants Est. completion 2005-04
    Other conditions: Binge Eating
    View official trial listing →
  • Completed NCT NCT00329407

    The Effects of Topiramate on Alcohol Use in Alcohol Dependent Subjects

    Not yet reported Boston University 10 participants Est. completion 2008-06 1 site
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT00345371

    Topiramate for the Treatment of Methamphetamine Dependence - 1

    Not yet reported National Institute on Drug Abuse (NIDA) 140 participants Est. completion 2008-12 8 sites
    Other conditions: Methamphetamine
    View official trial listing →
  • Withdrawn NCT NCT00370188

    Topiramate on Gambling-Related Behaviours

    Not yet reported Centre for Addiction and Mental Health 1 site
    Other conditions: Gambling
    View official trial listing →
  • Completed NCT NCT00393978

    Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania

    Not yet reported University of Cincinnati 75 participants Est. completion 2014-03 1 site
    Other conditions: Bipolar Disorder, Cannabis-Related Disorder
    View official trial listing →
  • Completed NCT NCT00394095

    Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine

    Not yet reported University of Cincinnati 31 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Bipolar Disorder, Weight Gain
    View official trial listing →
  • Suspended NCT NCT00396734

    The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence.

    Not yet reported Hadassah Medical Organization 40 participants Est. completion 2011-04 1 site
    Other conditions: Opioid-Related Disorders, Cocaine-Related Disorders
    View official trial listing →
  • Completed NCT NCT00404248

    Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35 participants Est. completion 2012-02 9 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00421603

    A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence

    Not yet reported New York State Psychiatric Institute 81 participants Est. completion 2010-05 1 site
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Status unknown NCT NCT00432549

    Detoxification and Treatment of Subjects With Medication Overuse Headache

    Not yet reported The New England Center for Headache, P.C. 60 participants Est. completion 2007-02 1 site
    Other conditions: Analgesic Rebound Headache
    View official trial listing →
  • Status unknown NCT NCT00448825

    Novel Pharmacotherapy for Dual Dependence

    Not yet reported Bankole Johnson 180 participants Est. completion 2013-06 2 sites Stand-alone
    Alcohol use disorder Other conditions: Cocaine Dependence
    View official trial listing →
  • Withdrawn NCT NCT00463775

    Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence

    Not yet reported Elizabeth Ralevski Est. completion 2009-05
    Alcohol use disorder Other conditions: Borderline Personality Disorder
    View official trial listing →
  • Completed NCT NCT00486291

    Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics

    Not yet reported VIVUS LLC 210 participants Est. completion 2008-04 9 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00518466

    Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults

    Not yet reported VIVUS LLC 64 participants Est. completion 2007-12 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00550394

    Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults

    Not yet reported University of Cincinnati 56 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Bipolar Disorder, Alcohol Abuse
    View official trial listing →
  • Status unknown NCT NCT00552526

    Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy

    Not yet reported Oslo University Hospital 60 participants Est. completion 2013-12 1 site
    Other conditions: Epilepsy, Mental Retardation
    View official trial listing →
  • Completed NCT NCT00553787

    Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions

    Not yet reported VIVUS LLC 2487 participants Est. completion 2009-06 6 sites Stand-alone
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00554216

    Study of VI-0521 Compared to Placebo in Treatment of Obesity in Adults

    Not yet reported VIVUS LLC 1267 participants Est. completion 2009-05 5 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00563368

    A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults

    Not yet reported VIVUS LLC 756 participants Est. completion 2008-09 2 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Terminated NCT NCT00563459

    Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

    Not yet reported SK Life Science, Inc. 89 participants Est. completion 2010-04
    Other conditions: Epilepsy, Seizures
    View official trial listing →
  • Withdrawn NCT NCT00571246

    The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress Disorder

    Not yet reported Yale University Est. completion 2016-06 1 site Stand-alone
    Alcohol use disorder Other conditions: Post Traumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT00572117

    Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder

    Not yet reported Stanford University 12 participants Est. completion 2014-07 1 site Stand-alone
    Alcohol use disorder Other conditions: Bipolar Disorder, Alcoholism
    View official trial listing →
  • Terminated NCT NCT00598923

    Preventing Epilepsy After Traumatic Brain Injury With Topiramate

    Not yet reported University of Pennsylvania 6 participants Est. completion 2009-02 Stand-alone
    Other conditions: Traumatic Brain Injury, Epilepsy
    View official trial listing →
  • Completed NCT NCT00600067

    A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults

    Not yet reported VIVUS LLC 130 participants Est. completion 2008-11 9 sites Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00606411

    Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder

    Not yet reported Massachusetts General Hospital 34 participants Est. completion 2018-11-29 1 site
    Other conditions: Sleep-Related Eating Disorder
    View official trial listing →
  • Completed NCT NCT00626925

    Topiramate Treatment of Problem Drinkers

    Not yet reported UConn Health 200 participants Est. completion 2013-11 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT00648934

    Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

    Not yet reported Mylan Pharmaceuticals Inc 36 participants Est. completion 2005-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649467

    Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

    Not yet reported Mylan Pharmaceuticals Inc 35 participants Est. completion 2005-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649740

    Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

    Not yet reported Mylan Pharmaceuticals Inc 36 participants Est. completion 2005-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT00659035

    Use of Driving Tests to Evaluate Patient Performance on Oral Opioids

    Asokumar Buvanendran 450 participants Est. completion 2026-12 1 site
    Other conditions: Chronic Pain
    View official trial listing →
  • Completed NCT NCT00685178

    Clinical Trial of Topiramate for Cocaine Addiction

    Not yet reported Johns Hopkins University 250 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT00701493

    A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40 participants Est. completion 2004-12
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT00704860

    Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism

    Not yet reported University of Ottawa 27 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Major Depression
    View official trial listing →
  • Completed NCT NCT00725920

    Placebo Controled Clinical Trial Using Topiramate To Treat Posttraumatic Stress Disorder (PTSD) Patients.

    Not yet reported Federal University of São Paulo 35 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Posttraumatic Stress Disorder
    View official trial listing →
  • Status unknown NCT NCT00731900

    Pharmacogenetic Study for Topiramate-Induced Cognitive Dysfunction

    National Taiwan University Hospital 100 participants Est. completion 2009-12 1 site
    Other conditions: Cognitive Dysfunction
    View official trial listing →
  • Withdrawn NCT NCT00732108

    Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness

    Not yet reported University of California, San Francisco 1 site Stand-alone
    Other conditions: Migraine, Headache, Dizziness
    View official trial listing →
  • Terminated NCT NCT00737633

    Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults

    Not yet reported VIVUS LLC 101 participants Est. completion 2009-06 9 sites Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00745251

    A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults

    Not yet reported, Not yet reported VIVUS LLC 45 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Sleep Apnea
    View official trial listing →
  • Completed NCT NCT00752466

    A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 75 participants Est. completion 2004-03
    Other conditions: Human Volunteers, Migraine
    View official trial listing →
  • Completed NCT NCT00753493

    Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients

    Not yet reported University of Minnesota 20 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Epilepsy, Migraines
    View official trial listing →
  • Completed NCT NCT00755716

    Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study

    Not yet reported UConn Health 57 participants Est. completion 2013-08 1 site
    Other conditions: Tobacco Dependence
    View official trial listing →
  • Completed NCT NCT00768209

    A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment

    Not yet reported VIVUS LLC 18 participants Est. completion 2009-07 2 sites Stand-alone
    Other conditions: Hepatic Impairment
    View official trial listing →
  • Completed NCT NCT00768404

    A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

    Not yet reported VIVUS LLC 32 participants Est. completion 2009-07 4 sites Stand-alone
    Other conditions: Renal Impairment
    View official trial listing →
  • Completed NCT NCT00768677

    Topiramate for Binge Eating Disorder Among Adolescents

    Not yet reported The Zucker Hillside Hospital 1 site
    Obstructive sleep apnea Other conditions: Eating Disorders
    View official trial listing →
  • Completed NCT NCT00769158

    Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study

    Not yet reported Bankole Johnson 4 participants Est. completion 2010-12 2 sites Stand-alone
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT00772031

    NINDS CRC Chronic Migraine Treatment Trial

    Not yet reported Anne Lindblad 191 participants Est. completion 2010-09 39 sites
    Other conditions: Chronic Migraine
    View official trial listing →
  • Withdrawn NCT NCT00777218

    Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine

    Not yet reported University of South Alabama Est. completion 2011-07 1 site
    Other conditions: Migraine
    View official trial listing →
  • Terminated NCT NCT00794313

    Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease

    Not yet reported Oregon Health and Science University 3 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00796367

    A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)

    Not yet reported VIVUS LLC 676 participants Est. completion 2010-07 Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00802412

    Topiramate to Aid Smoking Cessation in Alcohol Dependent Men

    Not yet reported VA Office of Research and Development 132 participants Est. completion 2015-06 1 site
    Alcohol use disorder Other conditions: Nicotine Dependence
    View official trial listing →
  • Completed NCT NCT00806260

    A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.

    Not yet reported VIVUS LLC 80 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT00812006

    A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis

    Not yet reported Organon and Co 108 participants Est. completion 2009-10-22
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT00842400

    A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.

    Not yet reported VIVUS LLC 20 participants Est. completion 2009-04 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00846495

    Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine

    Not yet reported Clinvest 55 participants Est. completion 2011-01 2 sites
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT00855738

    A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 111 participants Est. completion 2009-06
    Other conditions: Focal Epilepsy
    View official trial listing →
  • Terminated NCT NCT00862095

    Medical Therapies for Chronic Post-Traumatic Headaches

    Not yet reported Madigan Army Medical Center 64 participants Est. completion 2013-04 1 site Stand-alone
    Other conditions: Headache
    View official trial listing →
  • Terminated NCT NCT00862563

    Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism

    Not yet reported Boston Medical Center 85 participants Est. completion 2013-08 1 site
    Alcohol use disorder Other conditions: Alcoholism, Alcohol Abuse
    View official trial listing →
  • Completed NCT NCT00884884

    Aripiprazole and Topiramate on Free-Choice Alcohol Use

    Not yet reported, Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) 90 participants Est. completion 2015-10 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT00901784

    Bioequivalence Study of Topiramate Tablets 25mg Under Fasting Conditions

    Not yet reported Ranbaxy Laboratories Limited 28 participants Est. completion 2001-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00902473

    Bioequivalence Study of Topiramate Tablets 25mg Under Fed Conditions

    Not yet reported Ranbaxy Laboratories Limited 18 participants Est. completion 2001-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00904943

    Topiramate 25 mg Capsules Under Fed Conditions

    Not yet reported Teva Pharmaceuticals USA 18 participants Est. completion 2002-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00905164

    Topiramate 25 mg Capsules Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 24 participants Est. completion 2002-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00905346

    Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 24 participants Est. completion 2002-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00905567

    Topiramate 25 mg Tablets Under Fed Conditions

    Not yet reported Teva Pharmaceuticals USA 24 participants Est. completion 2001-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00905606

    Topiramate 25 mg Tablets Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 30 participants Est. completion 2001-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00939692

    Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Topiramate Tablets Under Fasted Conditions

    Not yet reported Torrent Pharmaceuticals Limited 26 participants Est. completion 2007-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00939705

    Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Topiramate Tablets Under Fed Conditions

    Not yet reported Torrent Pharmaceuticals Limited 18 participants 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT00956696

    Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study

    Chinese University of Hong Kong 50 participants Est. completion 2013-06 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT00986128

    A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder Patients

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 32 participants Est. completion 2002-10 Stand-alone
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00986336

    A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 56 participants Est. completion 2002-11 Stand-alone
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Withdrawn NCT NCT00988481

    Topiramate Augmentation in Bulimia Nervosa Partial Responders

    Not yet reported Neuropsychiatric Research Institute, Fargo, North Dakota Est. completion 2010-09 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT01000402

    Juvenile Bipolar Disorder Outpatient Program

    Not yet reported Federal University of Rio Grande do Sul 150 participants Est. completion 2014-11 1 site
    Other conditions: Bipolar Disorder, Attention Deficit Disorder With Hyperactivity
    View official trial listing →
  • Completed NCT NCT01030094

    A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy

    Janssen Korea, Ltd., Korea 140 participants Est. completion 2009-04
    Other conditions: Seizures, Convulsions, Epilepsy, Osteopenia, Osteoporosis
    View official trial listing →
  • Completed NCT NCT01060111

    An Efficacy and Tolerability Study of Topiramate in Participants With Migraine

    Not yet reported Janssen Korea, Ltd., Korea 250 participants Est. completion 2008-07 6 sites Stand-alone
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT01081795

    A Dose-Finding Study of Topiramate (JNS019) in Participants With Migraine

    Not yet reported Janssen Pharmaceutical K.K. 387 participants Est. completion 2009-01 29 sites Stand-alone
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT01087736

    Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy

    Not yet reported University of California, San Francisco 30 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: PTSD, Alcohol Abuse, Alcoholism
    View official trial listing →
  • Completed NCT NCT01096420

    Acupuncture in Chronic Migraine: A Randomized Controlled Trial

    Not yet reported Kuang Tien General Hospital 68 participants Est. completion 2010-08 1 site
    Other conditions: Patients With Chronic Migraine
    View official trial listing →
  • Completed NCT NCT01110434

    Biobehavioral Effects of Topiramate on Cannabis-Related Outcomes in Adolescents

    Not yet reported Brown University 66 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Cannabis Abuse, Cannabis Dependence
    View official trial listing →
  • Completed NCT NCT01114854

    A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)

    Not yet reported Supernus Pharmaceuticals, Inc. 69 participants Est. completion 2011-01 9 sites
    Other conditions: Epilepsy
    View official trial listing →
  • Status unknown NCT NCT01135602

    Topiramate for Hospitalized Patients With Alcoholism: a 12-week Study

    Not yet reported Chiang Mai University 150 participants Est. completion 2012-03 2 sites Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT01142193

    Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

    Not yet reported Upsher-Smith Laboratories 249 participants Est. completion 2013-01 69 sites
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT01145677

    Efficacy of Topiramate for Hospitalized Patients With Alcoholism

    Not yet reported, Not yet reported Chiang Mai University 90 participants Est. completion 2011-06 4 sites Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT01161017

    Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile?

    Not yet reported Rambam Health Care Campus 67 participants Est. completion 2014-05 1 site
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT01182766

    New Treatment for Alcohol and Nicotine Dependence

    Not yet reported, Not yet reported University of Virginia 236 participants Est. completion 2017-10-06 4 sites Stand-alone
    Alcohol use disorder Other conditions: Nicotine Dependence
    View official trial listing →
  • Completed NCT NCT01191086

    Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures

    Not yet reported Upsher-Smith Laboratories 210 participants Est. completion 2014-05 68 sites Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT01229735

    Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

    Not yet reported UCB Korea Co., Ltd. 343 participants Est. completion 2015-05 24 sites
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT01241019

    Safety and Efficacy of Topiramate in Neonates With Hypoxic Ischemic Encephalopathy Treated With Hypothermia

    Not yet reported Meyer Children's Hospital IRCCS 64 participants Est. completion 2013-12 2 sites Stand-alone
    Other conditions: Hypoxic Ischemic Encephalopathy
    View official trial listing →
  • Terminated NCT NCT01351753

    Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity

    Not yet reported University of Iowa 128 participants Est. completion 2014-01-09 1 site Stand-alone
    Metabolic syndrome Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01384279

    The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity

    Not yet reported Beitou Armed Forces Hospital, Taipei, Taiwan 25 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01390909

    Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database

    GlaxoSmithKline 12386 participants Est. completion 2011-01
    Other conditions: Epilepsy
    View official trial listing →
  • Terminated NCT NCT01408641

    Topiramate for Alcohol Use in Posttraumatic Stress Disorder

    Not yet reported University of Maryland, Baltimore 4 participants Est. completion 2013-08 1 site Stand-alone
    Alcohol use disorder Other conditions: Alcoholism, Alcohol Abuse, PTSD, Posttraumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT01426542

    Preventing Brain Injury in Infants With Congenital Heart Disease

    Not yet reported University of California, Davis 24 participants Est. completion 2017-07-28 1 site Stand-alone
    Other conditions: Cyanotic Congenital Heart Disease
    View official trial listing →
  • Completed NCT NCT01439438

    Topiramate Bioequivalence Study Brazil - Fast

    Not yet reported GlaxoSmithKline 26 participants Est. completion 2011-09-11 1 site
    Other conditions: Epilepsy, Tonic-Clonic
    View official trial listing →
  • Terminated NCT NCT01581281

    The Childhood and Adolescent Migraine Prevention Study

    Not yet reported Children's Hospital Medical Center, Cincinnati 488 participants Est. completion 2016-01 35 sites
    Other conditions: Migraine, Migraine Disorders, Headache
    View official trial listing →
  • Completed NCT NCT01627860

    First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical Patients

    Not yet reported Johnson & Johnson Taiwan Ltd 55 participants Est. completion 2011-01 Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT01641445

    Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms

    Not yet reported, Not yet reported Brown University 82 participants Est. completion 2017-04-12 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT01682681

    An Observational Study to Evaluate Long-term Retention Rate of Topiramate in Participants With Epilepsy

    Janssen Korea, Ltd., Korea 1234 participants Est. completion 2009-05
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT01689649

    A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy

    Not yet reported Janssen Research & Development, LLC 139 participants Est. completion 2010-01-19 2 sites Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT01700387

    A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency

    Not yet reported Cady, Roger, M.D. 20 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Chronic Migraine
    View official trial listing →
  • Completed NCT NCT01713946

    A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures

    Not yet reported Novartis Pharmaceuticals 366 participants Est. completion 2017-10-25 104 sites Stand-alone
    Other conditions: Tuberous Sclerosis Complex-associated Refractory Seizures
    View official trial listing →
  • Completed NCT NCT01749215

    A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD

    Not yet reported University of California, San Francisco 151 participants Est. completion 2019-07 1 site Stand-alone
    Alcohol use disorder Other conditions: Posttraumatic Stress Disorder (PTSD)
    View official trial listing →
  • Completed NCT NCT01750268

    Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI

    Not yet reported University of California, San Francisco 32 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Traumatic Brain Injury (TBI), Hazardous and Harmful Alcohol Use
    View official trial listing →
  • Terminated NCT NCT01764685

    Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers

    Not yet reported University of Pennsylvania 4 participants Est. completion 2014-01 1 site Stand-alone
    Alcohol use disorder Other conditions: Heavy Drinking, HIV
    View official trial listing →
  • Terminated NCT NCT01765218

    Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy

    Not yet reported, Not yet reported Kristin R Hoffman 34 participants Est. completion 2022-01-27 1 site
    Other conditions: Hypoxic Ischemic Encephalopathy
    View official trial listing →
  • Terminated NCT NCT01789047

    Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

    Not yet reported Rush University Medical Center 42 participants Est. completion 2016-07 5 sites
    Other conditions: Idiopathic Parkinson's Disease, Drug Induced Dyskinesia
    View official trial listing →
  • Completed NCT NCT01799590

    Continuous Treatment Study of Topiramate in Migraine Participants

    Not yet reported Janssen Pharmaceutical K.K. 296 participants Est. completion 2009-11 25 sites Stand-alone
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT01811940

    Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence

    Not yet reported, Not yet reported New York State Psychiatric Institute 169 participants Est. completion 2017-06 2 sites Stand-alone
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT01834404

    Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients

    Not yet reported Mayo Clinic 24 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01836874

    A Study of Prophylaxis for Migraine Patients With Topiramate in India

    Janssen-Cilag Ltd. 209 participants Est. completion 2008-07
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT01843699

    Topiramate Trial for Pathological Gamblers

    Not yet reported University of Sao Paulo 38 participants 1 site Stand-alone
    Other conditions: Pathological Gambling
    View official trial listing →
  • Completed NCT NCT01859013

    Topiramate in Adolescents With Severe Obesity

    Not yet reported University of Minnesota 34 participants Est. completion 2017-04 1 site Stand-alone
    Other conditions: Obesity, Morbid, Obesity, Weight Loss
    View official trial listing →
  • Status unknown NCT NCT01868204

    Pharmacogenetic and Neurofunctional Brain Areas Study in Obese Patients With Binge Eating Disorder

    Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente 60 participants Est. completion 2014-03 1 site
    Other conditions: Obesity, Binge Eating Disorder
    View official trial listing →
  • Completed NCT NCT01889602

    Characterizing and Predicting Drug Effects on Cognition

    Not yet reported University of Minnesota 60 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Cognitive Deficits
    View official trial listing →
  • Completed NCT NCT01922934

    A Toolbox Approach to Obesity Treatment in Primary Care

    Not yet reported Denver Health and Hospital Authority 4730 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01950520

    Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 47 participants Est. completion 2024-06-11 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Withdrawn NCT NCT01970566

    Comparison of the Effect of Intense-Exercise/Moderate-Calorie, Topiramate-Phentermine and Cognitive Behavioral Therapy on Obesity

    Not yet reported US Department of Veterans Affairs Est. completion 2017-11 1 site
    Other conditions: Obesity, Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT02040311

    Topiramate: Long-Term Maintenance of Weight Loss Induced by Low-Calorie Diet in Obese Subjects

    Not yet reported University of Copenhagen 701 participants Est. completion 2002-06 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Terminated NCT NCT02074904

    Topiramate's Effects on Heavy Drinking

    Not yet reported University of Pennsylvania 1 participants Est. completion 2017-03 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Status unknown NCT NCT02098941

    Evaluate Retention Rate of Topiramate, Levetiracetam and Oxcarbazepine in a Long-term Epilepsy Treatment

    Seoul National University Hospital 2500 participants Est. completion 2014-12 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02113787

    Switchability Study Between Brand and Generic Topiramate

    Not yet reported Seoul National University Hospital 24 participants Est. completion 2017-05 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02138058

    Topiramate Trial for Compulsive Buying

    Not yet reported University of Sao Paulo 42 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Compulsive Shopping
    View official trial listing →
  • Terminated NCT NCT02169830

    Trial of Nortriptyline and Topiramate in the Initial Treatment of Vestibular Migraine

    Not yet reported St. Louis University 35 participants Est. completion 2019-10-30 1 site
    Other conditions: Migraine Disorders
    View official trial listing →
  • Completed NCT NCT02191579

    Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults

    Not yet reported Allergan 282 participants Est. completion 2017-09-01 32 sites
    Other conditions: Migraine Disorders
    View official trial listing →
  • Completed NCT NCT02201251

    A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy

    Not yet reported Janssen Research & Development, LLC 63 participants Est. completion 2020-04-30 41 sites Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Status unknown NCT NCT02205931

    Ketogenic Diet in Infants With Epilepsy (KIWE)

    Not yet reported University College, London 160 participants Est. completion 2019-06 11 sites
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02229214

    Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects

    Not yet reported VIVUS LLC 51 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02239913

    Topiramate-Phentermine Combinations for Cocaine Dependence

    Not yet reported University of Kentucky 38 participants Est. completion 2019-09 1 site Stand-alone
    Other conditions: Cocaine Use Disorder
    View official trial listing →
  • Completed NCT NCT02273804

    Topiramate and Severe Obesity

    Not yet reported Assistance Publique - Hôpitaux de Paris 18 participants Est. completion 2018-01-23 1 site Stand-alone
    Other conditions: Obese Children and Adolescents
    View official trial listing →
  • Completed NCT NCT02283814

    A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate

    Not yet reported Bial - Portela C S.A. 32 participants Est. completion 2007-02
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02300051

    Intervention Study for Individuals With Compulsive Sexual Behavior

    Not yet reported University of Sao Paulo General Hospital 135 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Compulsive Sexual Behavior
    View official trial listing →
  • Completed NCT NCT02301416

    Qsymia as an Adjunct to Surgical Therapy in the Superobese

    Not yet reported Wake Forest University Health Sciences 25 participants Est. completion 2018-06-27 1 site Stand-alone
    Other conditions: Obesity, Metabolic Surgery, Weight Loss, Bariatric Surgery Procedures
    View official trial listing →
  • Completed NCT NCT02371889

    A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers

    Not yet reported University of Pennsylvania 320 participants Est. completion 2020-02 2 sites Stand-alone
    Alcohol use disorder Other conditions: Alcoholism
    View official trial listing →
  • Terminated NCT NCT02374567

    Pharmacovigilance in Gerontopsychiatric Patients

    Not yet reported Hannover Medical School 407 participants Est. completion 2017-06-28 5 sites Stand-alone
    Other conditions: Dementia, Depression, Schizophrenia, Psychosomatic Disorders, Anxiety Disorders
    View official trial listing →
  • Completed NCT NCT02403687

    Prospective Analgesic Compound Efficacy (PACE) Study

    Express Specialty Pharmacy 300 participants Est. completion 2017-02
    Other conditions: Arthritis, Tendonitis, Gout, Radiculopathy, Muscle Spasms, Synovitis, Migraine, Headache
    View official trial listing →
  • Completed NCT NCT02424318

    Topiramate and Cerebrovascular Response in Migraineurs

    Not yet reported SMG-SNU Boramae Medical Center 19 participants Est. completion 2010-12 Stand-alone
    Other conditions: Migraine Disorders
    View official trial listing →
  • Status unknown NCT NCT02429596

    A Trial of Generic Substitution of Antiepileptic Drugs

    Not yet reported IRCCS National Neurological Institute "C. Mondino" Foundation 200 participants Est. completion 2015-05 16 sites
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02497443

    Safety of Autologous MSC Infusion to Treat Epilepsy

    Not yet reported, Not yet reported Ministry of Public Health, Republic of Belarus 60 participants Est. completion 2019-12 Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02553824

    FDA Approved Medication to Reduce Binge Eating and/or Purging

    Not yet reported Stanford University 22 participants Est. completion 2017-04-15 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Binge Eating Disorder
    View official trial listing →
  • Completed NCT NCT02635386

    EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

    Not yet reported Woman's 119 participants Est. completion 2020-10-09 1 site
    Other conditions: Polycystic Ovary Syndrome, Obesity
    View official trial listing →
  • Completed NCT NCT02639598

    Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis

    Not yet reported Taipei Veterans General Hospital, Taiwan 62 participants Est. completion 2015-03
    Other conditions: Chronic Migraine
    View official trial listing →
  • Withdrawn NCT NCT02643719

    Migraine Treatment in ED

    Not yet reported NYU Langone Health Est. completion 2017-10
    Other conditions: Migraine
    View official trial listing →
  • Status unknown NCT NCT02645370

    Efficacy and Safety of Danzhen

    Not yet reported Xijing Hospital 3300 participants 1 site
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT02659475

    Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)

    Not yet reported Lindner Center of HOPE 10 participants Est. completion 2016-09 1 site
    Other conditions: Binge Eating Disorder
    View official trial listing →
  • Enrolling by invitation NCT NCT02670161

    Quality Improvement and Practice Based Research in Neurology Using the EMR

    Not yet reported Endeavor Health 3300 participants Est. completion 2027-12 1 site
    Cardiovascular disease Other conditions: Brain Tumors, Epilepsy, Migraine, Mild Cognitive Impairment, Concussion, Multiple Sclerosis, Neuropathy, Parkinson's, Restless Legs Syndrome
    View official trial listing →
  • Completed NCT NCT02707965

    Characterization of Epilepsy Patients BEEP 2b

    Not yet reported Food and Drug Administration (FDA) 21 participants Est. completion 2018-09-04 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02714062

    A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents

    Not yet reported VIVUS LLC 42 participants Est. completion 2016-11 4 sites Stand-alone
    Other conditions: Pediatric Obesity, Childhood Obesity
    View official trial listing →
  • Terminated NCT NCT02727101

    Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.

    Not yet reported Mid-Atlantic Epilepsy and Sleep Center, LLC 8 participants Est. completion 2017-07 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Active, not recruiting NCT NCT02808533

    Topiramate and Schizophrenia: Effects on Weight and Psychopathology

    Not yet reported Centre for Addiction and Mental Health 50 participants Est. completion 2026-08 1 site Stand-alone
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Terminated NCT NCT02810483

    Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks

    Not yet reported Assistance Publique - Hôpitaux de Paris 69 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT02878798

    Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)

    Not yet reported Virginia Commonwealth University 132 participants Est. completion 2021-09-28 20 sites Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02884050

    Physiologic Effects of Topiramate on Cognition

    Not yet reported University of Florida 11 participants Est. completion 2011-01 Stand-alone
    Other conditions: Alteration of Cognitive Function
    View official trial listing →
  • Withdrawn NCT NCT02945839

    Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department

    Not yet reported NYU Langone Health Est. completion 2019-12 1 site
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT02993861

    Pharmacokinetics of Anti-epileptic Drugs in Obese Children

    Christoph P Hornik, MD MPH 106 participants Est. completion 2019-10-17 10 sites
    Other conditions: Epilepsy, Obese
    View official trial listing →
  • Terminated NCT NCT03018704

    Topiramate Treatment of Alcohol Use Disorders in African Americans

    Not yet reported VA Office of Research and Development 79 participants Est. completion 2021-12-31 2 sites Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT03120468

    Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder

    Not yet reported Nassima Ait-Daoud Tiouririne 17 participants Est. completion 2019-06-30 1 site Stand-alone
    Other conditions: Alcoholism
    View official trial listing →
  • Completed NCT NCT03125525

    Clinical Experience With Transcutaneous Supraorbital Nerve Stimulation in Refractory Migraine

    Corfu Headache Clinic 37 participants Est. completion 2016-06-30
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT03176953

    Topiramate and Prolonged Exposure

    Not yet reported, Not yet reported VA Office of Research and Development 100 participants Est. completion 2023-09-30 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT03196466

    Population Pharmacokinetics of Antiepileptic in Pediatrics

    Assistance Publique - Hôpitaux de Paris 753 participants Est. completion 2023-06-15 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Withdrawn NCT NCT03280342

    Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine

    Not yet reported University of Minnesota Est. completion 2018-09-13 2 sites
    Other conditions: Migraine, Headache
    View official trial listing →
  • Suspended NCT NCT03307863

    Effect of Anti-epileptic Drugs on Etonogestrel-releasing Implant Pharmacokinetics in Women With Epilepsy

    Not yet reported University of Sao Paulo 69 participants Est. completion 2028-11-30 1 site Stand-alone
    Other conditions: Contraception, Drug Interactions
    View official trial listing →
  • Completed NCT NCT03308669

    A Study of Lasmiditan in Healthy Participants When Co-administered With Topiramate

    Not yet reported Eli Lilly and Company 30 participants Est. completion 2017-12-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03335163

    The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users

    Not yet reported University of Colorado, Denver 48 participants Est. completion 2021-04-22 1 site Stand-alone
    Other conditions: Migraine, Migraine;Menstrual, Contraception
    View official trial listing →
  • Status unknown NCT NCT03354507

    Use of Sodium Bicarbonate in Patients Treated With Topiramate

    Not yet reported McMaster Children's Hospital 40 participants Est. completion 2018-12 1 site
    Other conditions: Epilepsy, Metabolic Acidosis, Tubular Acidosis; Renal
    View official trial listing →
  • Completed NCT NCT03374956

    Individualized Obesity Pharmacotherapy

    Not yet reported Mayo Clinic 193 participants Est. completion 2022-05-26 1 site Added to GLP-1
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03461874

    ACT Therapy for HF Migraine

    Not yet reported Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 64 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Migraine Without Aura
    View official trial listing →
  • Status unknown NCT NCT03479086

    Defining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in Australia

    Not yet reported South West Sydney Local Health District 180 participants Est. completion 2020-11-01 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Terminated NCT NCT03603080

    Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve Gastrectomy

    Not yet reported Hartford Hospital 12 participants Est. completion 2022-09-01 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Withdrawn NCT NCT03636958

    Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy

    Not yet reported Assistance Publique Hopitaux De Marseille Est. completion 2026-12-01 2 sites Stand-alone
    Other conditions: Refractory Epilepsy
    View official trial listing →
  • Completed NCT NCT03671681

    Mindfulness Therapy for Chronic Migraine

    Not yet reported Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 177 participants Est. completion 2023-11-20 1 site Stand-alone
    Other conditions: Chronic Migraine, Medication Overuse Headache
    View official trial listing →
  • Completed NCT NCT03689114

    Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)

    Not yet reported Mario Negri Institute for Pharmacological Research 58 participants Est. completion 2024-06-30 1 site Stand-alone
    Other conditions: Epilepsies, Partial
    View official trial listing →
  • Completed NCT NCT03712917

    Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic Migraine

    Not yet reported Ataturk University 120 participants Est. completion 2019-03-31 1 site
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT03767062

    Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches

    Not yet reported Ataturk University 90 participants Est. completion 2019-03-31 1 site
    Other conditions: Medication Overuse Headache, Chronic Migraine, Headache
    View official trial listing →
  • Completed NCT NCT03799198

    Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity

    Not yet reported Novo Nordisk A/S 200 participants Est. completion 2020-05-22 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03828539

    Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine

    Not yet reported Novartis Pharmaceuticals 777 participants Est. completion 2020-07-29 79 sites
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT03922945

    A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity

    Not yet reported VIVUS LLC 223 participants Est. completion 2021-04-16 1 site Stand-alone
    Other conditions: Adolescent Obesity, Obesity in Adolescence, Adolescent Overweight
    View official trial listing →
  • Completed NCT NCT04007393

    SMART Use of Medication for the Treatment of Adolescent Severe Obesity

    Not yet reported University of Minnesota 150 participants Est. completion 2025-03-11 1 site
    Other conditions: Adolescent Obesity
    View official trial listing →
  • Completed NCT NCT04043702

    Combination of Topiramate and Empagliflozin is Considered a Good Option for the Treatment of Obesity

    Ministry of Health and Population, Egypt 200 participants Est. completion 2019-07-29 1 site
    Other conditions: Obesity
    View official trial listing →
  • Terminated NCT NCT04050293

    Therapy for Migraine Prevention in Children 6-11 Years of Age

    Not yet reported Supernus Pharmaceuticals, Inc. 26 participants Est. completion 2023-03-01 1 site Stand-alone
    Other conditions: Migraine Disorders, Headache Disorders
    View official trial listing →
  • Completed NCT NCT04095104

    Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds

    Not yet reported University of Colorado, Denver 13 participants Est. completion 2022-01-25 1 site Stand-alone
    Other conditions: Obesity, Morbid, Bariatric Surgery, Adolescent, Young Adult, Drug Therapy
    View official trial listing →
  • Status unknown NCT NCT04154813

    Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment

    Not yet reported Shanghai Mental Health Center 550 participants Est. completion 2022-11-30 1 site Stand-alone
    Other conditions: Fluoxetine
    View official trial listing →
  • Completed NCT NCT04298203

    Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity

    Not yet reported University of Minnesota 100 participants Est. completion 2026-05-22 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT04401137

    The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects

    Not yet reported SK Chemicals Co., Ltd. 42 participants Est. completion 2020-10-06 1 site Stand-alone
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT04404439

    Treatment of Tinnitus With Migraine Medications

    Not yet reported University of California, Irvine 78 participants Est. completion 2023-12-30 1 site Stand-alone
    Other conditions: Tinnitus, Subjective, Tinnitus
    View official trial listing →
  • Completed NCT NCT04408586

    Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker

    Not yet reported Mayo Clinic 80 participants Est. completion 2022-10-11 1 site
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT04453306

    Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome

    Not yet reported Hospital de Clinicas de Porto Alegre 80 participants Est. completion 2021-12 1 site Stand-alone
    Other conditions: Obesity, Polycystic Ovary Syndrome, Hyperandrogenism
    View official trial listing →
  • Completed NCT NCT04523935

    Excessive Crying in Children With Cerebral Palsy and Communication Deficits

    Not yet reported Sathbhavana Brain Clinic 131 participants Est. completion 2020-08-04
    Other conditions: Cerebral Palsy, Excessive Crying, Pain
    View official trial listing →
  • Terminated NCT NCT04531176

    EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial

    Not yet reported The Cleveland Clinic 74 participants Est. completion 2023-08-04 1 site Added to GLP-1
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Withdrawn NCT NCT04572217

    Medications After Adolescent Bariatric Surgery

    Not yet reported Janey Pratt Est. completion 2022-06-01 1 site Stand-alone
    Other conditions: Pediatric Obesity
    View official trial listing →
  • Terminated NCT NCT04581603

    CBT-I Augmentation of Medication for Drinking in AUD

    Not yet reported VA Office of Research and Development 82 participants Est. completion 2025-01-20 2 sites
    Alcohol use disorder
    View official trial listing →
  • Withdrawn NCT NCT04613024

    Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty

    Not yet reported Stanford University Est. completion 2027-07-01 1 site
    Other conditions: Weight Loss, Pain, Postoperative
    View official trial listing →
  • Completed NCT NCT04621929

    Phentermine/Topiramate for Uric Acid Stones

    Not yet reported University of Florida 19 participants Est. completion 2024-11-14 1 site Stand-alone
    Type 2 diabetesPrediabetes Other conditions: Obesity, Uric Acid Stones
    View official trial listing →
  • Status unknown NCT NCT04759196

    Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas

    Not yet reported Université de Sherbrooke 56 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Chronic Subdural Hematoma, Epilepsy; Seizure, Cortical Depression; Cortical Depolarization, Nonepileptic, Stereotypical and Intermittent Symptoms, NESIS
    View official trial listing →
  • Active, not recruiting NCT NCT04881799

    Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity

    Not yet reported University of Minnesota 13 participants Est. completion 2026-10-27 1 site Stand-alone
    Other conditions: Pediatric Obesity
    View official trial listing →
  • Completed NCT NCT04986631

    Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP

    Not yet reported University of Minnesota 65 participants Est. completion 2024-09-26 1 site Stand-alone
    Other conditions: Obesity, Childhood
    View official trial listing →
  • Withdrawn NCT NCT05209984

    A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight

    Not yet reported Eurofarma Laboratorios S.A. Est. completion 2028-03 2 sites Stand-alone
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Withdrawn NCT NCT05209997

    Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity

    Eurofarma Laboratorios S.A. Est. completion 2025-12-01 2 sites
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT05215418

    A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects

    Not yet reported VIVUS LLC 565 participants Est. completion 2023-04-17 28 sites Stand-alone
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT05236166

    Multicentre Study on Rapid Versus Slow Withdrawal of Antiepileptic Monotherapy

    Not yet reported University Magna Graecia 48 participants Est. completion 2021-11-01 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT05378503

    Phase IV Study of Qsymia in Obese Patients

    Not yet reported Alvogen Korea 232 participants Est. completion 2023-10-30 8 sites
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT05403229

    The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss

    Not yet reported Chang Gung Memorial Hospital 140 participants Est. completion 2025-09 1 site Stand-alone
    Substance use disorder
    View official trial listing →
  • Status unknown NCT NCT05516251

    Transcutaneous Supraorbital Nerve Stimulator Versus Topiramate in Prevention of Recurrent Migraine

    Not yet reported Tongji Hospital 200 participants Est. completion 2023-09-30 1 site
    Other conditions: Migraine, Classic
    View official trial listing →
  • Completed NCT NCT05579249

    A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

    Not yet reported Novo Nordisk A/S 500 participants Est. completion 2024-11-27 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05663749

    Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics

    Not yet reported All India Institute of Medical Sciences, Bhubaneswar 60 participants Est. completion 2023-08-20 1 site Stand-alone
    Metabolic syndrome Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT05748483

    Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine

    Not yet reported AbbVie 545 participants Est. completion 2026-06-02 81 sites Stand-alone
    Other conditions: Migraine
    View official trial listing →
  • Completed NCT NCT05756621

    Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

    University of Milano Bicocca 84 participants Est. completion 2025-12-31 10 sites
    Other conditions: Status Epilepticus, Cardiac Arrest
    View official trial listing →
  • Active, not recruiting NCT NCT05756764

    Anti-obesity Pharmacotherapy and Inflammation

    Louisiana State University Health Sciences Center in New Orleans 30 participants Est. completion 2026-02-20 2 sites
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT05759845

    Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis

    Not yet reported Dr. Reaz Mahmud 150 participants Est. completion 2023-05-31 1 site
    Other conditions: Migraine
    View official trial listing →
  • Withdrawn NCT NCT05812183

    Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity

    Not yet reported University of California, Los Angeles Est. completion 2025-02-12 Stand-alone
    Other conditions: Dyspnea, Quality of Life
    View official trial listing →
  • Withdrawn NCT NCT05834062

    Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity

    Not yet reported University of Minnesota Est. completion 2027-08 1 site
    Other conditions: Obesity, Adolescent
    View official trial listing →
  • Status unknown NCT NCT05860062

    Vitamin D Supplementation in Episodic and Chronic Tension-type Headache

    Not yet reported Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social 20 participants Est. completion 2023-12-20 1 site Stand-alone
    Other conditions: Chronic Tension-Type Headache
    View official trial listing →
  • Completed NCT NCT05940935

    The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations

    Trakya University 35 participants Est. completion 2023-08-15 1 site
    Other conditions: Metabolic Acidosis, Antiepileptic Drugs, Craniotomy, Anesthesia Management
    View official trial listing →
  • Status unknown NCT NCT05958160

    Modified Atkins Diet Versus Topiramate In Children With Epileptic Spasms Refractory To Hormonal Treatment: A Randomized Open-Label Study

    Not yet reported, Not yet reported Lady Hardinge Medical College 70 participants Est. completion 2024-10-31 1 site
    Other conditions: Epileptic Spasms, Failed Hormonal Therapy
    View official trial listing →
  • Status unknown NCT NCT06089356

    Zolmitriptane as Prophylaxis for Chilhood Migraine

    Not yet reported Tanta University 90 participants Est. completion 2024-01-01 1 site
    Other conditions: Migraine
    View official trial listing →
  • Status unknown NCT NCT06243692

    Lacosamide Versus Topiramate in Migraine

    Not yet reported Kafrelsheikh University 600 participants Est. completion 2025-02-25 1 site
    Other conditions: Migraine Disorders
    View official trial listing →
  • Completed NCT NCT06248931

    Valproate Versus Topiramate in Migraine

    Not yet reported Kafrelsheikh University 600 participants Est. completion 2024-06-30 1 site
    Other conditions: Migraine Disorders
    View official trial listing →
  • Status unknown NCT NCT06282783

    Studying Topiramate for Re-Activating the HIV-1 Reservoir

    Not yet reported, Not yet reported Erasmus Medical Center 12 participants Est. completion 2025-08 1 site Stand-alone
    Other conditions: HIV-1-infection, Hiv, HIV Infections, HIV I Infection
    View official trial listing →
  • Active, not recruiting NCT NCT06299891

    Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

    Not yet reported Seattle Children's Hospital 24 participants Est. completion 2026-11-30 2 sites Stand-alone
    Other conditions: Hypothalamic Obesity, Hypothalamic Tumor, Craniopharyngioma
    View official trial listing →
  • Completed NCT NCT06347497

    Zonisamide Versus Topiramate in Migraine

    Not yet reported Kafrelsheikh University 600 participants Est. completion 2026-04-30 1 site Stand-alone
    Other conditions: Migraine
    View official trial listing →
  • Not yet recruiting NCT NCT06499116

    Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care

    Not yet reported Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 460 participants Est. completion 2026-12 Stand-alone
    Other conditions: Migraine
    View official trial listing →
  • Active, not recruiting NCT NCT06799169

    Management of Acute Tinnitus With Migraine Medications

    Not yet reported University of California, Irvine 100 participants Est. completion 2026-12 1 site
    Other conditions: Tinnitus
    View official trial listing →
  • Active, not recruiting NCT NCT06854614

    Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)

    Not yet reported The Cleveland Clinic 150 participants Est. completion 2028-04-28 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT06877572

    Weight Loss Management in Endometrial Cancer Survivors

    University of Kansas Medical Center 50 participants Est. completion 2030-10 1 site
    Other conditions: Endometrial Cancer Survivors, Weight Management, Early Stage Endometrial Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07027969

    Metabolic Surgery for Atrial Fibrillation Elimination

    Not yet reported Ali Aminian 100 participants Est. completion 2030-03-31 1 site
    Other conditions: Atrial Fibrillation, Obesity and Obesity-related Medical Conditions
    View official trial listing →
  • Active, not recruiting NCT NCT07188545

    Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)

    Ohio State University 23280000 participants Est. completion 2029-06-30 1 site
    Metabolic syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07203248

    Chinese Real-world Study of Treatment of Vestibular Migraine

    Second Affiliated Hospital, Zhejiang University, School of Medicine 2000 participants Est. completion 2028-12
    Other conditions: Vestibular Migraine, Dizziness, Vertigo
    View official trial listing →
  • Not yet recruiting NCT NCT07384624

    Combining Latency Reversing Agents to Address the HIV Reservoir

    Not yet reported, Not yet reported Erasmus Medical Center 30 participants Est. completion 2028-07 4 sites Stand-alone
    Other conditions: HIV (Human Immunodeficiency Virus), HIV -1 Infection
    View official trial listing →
  • Completed NCT NCT07588750

    Retrospective Evaluation of Sibutramine-Topiramate Therapy for Obesity in Real-World Outpatient Practice

    Falquetomed 278 participants Est. completion 2026-09-01 1 site
    Other conditions: Obesity & Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07655440

    Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)

    Not yet reported Stanford University 120 participants Est. completion 2031-07
    Other conditions: Migraine Associated Vertigo, Tinnitus, Migraine, Vestibular Migraine
    View official trial listing →
  • Active, not recruiting NCT NCT07707544

    Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary Management

    Not yet reported Sohag University 30 participants Est. completion 2026-12-01 1 site
    Other conditions: Idiopathic Intracranial Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07728812

    Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy

    Not yet reported Phenomix Sciences 424 participants Est. completion 2029-01-01 Stand-alone
    Other conditions: Obesity & Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07790913

    Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma

    Not yet reported St. Jude Children's Research Hospital 100 participants Est. completion 2031-08 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia in Remission, Hodgkin Lymphoma in Remission, Non-Hodgkin Lymphoma in Remission, Cancer Survivorship
    View official trial listing →
  • Not yet recruiting NCT NCT07802158

    Discontinuing Psychotropic Medication Before Psychotherapy for PTSD

    Academic Centre for Dentistry in Amsterdam 100 participants Est. completion 2026-09-02
    Other conditions: Post-traumatic Stress Disorder (PTSD)
    View official trial listing →
  • Not yet recruiting NCT NCT07832084

    Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s

    Not yet reported Jing Luo 60 participants Est. completion 2028-09-30 1 site Stand-alone
    Other conditions: Obesity & Overweight, Cardiometabolic Health Indicators
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.